Open an account

Pressure Biosciences

PBIO · OTC

$0.0005+$0.00 (+0.00%)TodayMarket closed ·
Prev close $0.0005

About PBIO

Pressure BioSciences, Inc. engages in the manufacture and distribution of infectious disease diagnostic products. The company is headquartered in Canton, Massachusetts and currently employs 15 full-time employees. The firm's segments include Industrial, Consumer and Parent. Its Industrial segment contains the Ultra Shear Technology (UltraShear or UST), BaroFold Technology (BaroFold), and Pressure Cycling Technology (PCT) Platforms. Its products include Barocyclers, Barocycler Accessories, External Pressure Calibration Device Kit, MicroTubes for Barocyclers, MicroTube Accessories for Barocyclers, BaroShear K45, HUB High Pressure Generators and Accessories, HP Cell From ISS, RF1700 Mini Ultra-High Pressure Pump, SHREDDER SG3 and SHREDDER Tubes, and Service Contracts. Its Consumer segment represents the activity of Uncle Bud’s. Uncle Bud’s offers products direct-to-consumer online and through retail chains. Uncle Bud’s is engaged in hemp seed oil, cannabidiol (CBD), and the health and wellness industry.

Employees
16
Headquarters
Canton, Massachusetts
Listed
Oct 31, 1996
Sector
Health Care
Industry
Life Sciences Tools & Services
Website
pressurebiosciences.com

PBIO key statistics

Market cap
21.48K
Price-earnings ratio
—
Dividend yield
—
Average volume
14.34K
Volume
9
Open price
$0.0002
High today
$0.0005
Low today
$0.0002
52 Week high
$0.20
52 Week low
$0.0001

Pressure Biosciences (PBIO) at a glance

As of Oct 13, 2026, Pressure Biosciences (PBIO) shares are priced at $0.0005, giving the company a market cap of 21.48K.

Today the stock has traded between $0.0002 and $0.0005. The current price is 150.0% above the day's low and 0.0% below its high.

Volume so far is 9 shares, below the average of 14.34K shares a day.

Over the past year Pressure Biosciences has ranged from $0.0001 to $0.20, and now sits 0% of the way up that range.

Pressure Biosciences met or beat analyst EPS estimates in 4 of the last 8 quarters. In Q3 FY14 it reported -$2.10 per share against an estimate of -$3.98.

PBIO earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 4 of the last 8 quarters, by 30.6% on average.

  1. Q1 FY11: reported -$10.20 per share against an estimate of -$10.86
  2. Q2 FY11: reported -$12.30 per share against an estimate of -$11.32
  3. Q2 FY13: reported -$3.00 per share against an estimate of -$1.84
  4. Q3 FY13: reported -$1.80 per share against an estimate of -$1.84
  5. Q4 FY13: reported -$4.80 per share against an estimate of -$2.75
  6. Q1 FY14: reported -$7.50 per share against an estimate of -$3.06
  7. Q2 FY14: reported -$1.50 per share against an estimate of -$4.59
  8. Q3 FY14: reported -$2.10 per share against an estimate of -$3.98

Similar companies

Companies in the same industry as Pressure Biosciences

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.